Tilray
OrganizationRelationship Network
Event Timeline
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
Privateer
|
Business associate |
5
|
1 | |
|
organization
Alef Biotechnology
|
Business associate |
5
|
1 | |
|
organization
ABG
|
Business associate |
5
|
1 | |
|
person
Authentic Brands Group
|
Business associate |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Partnership deal established between Tilray and ABG. | N/A | View |
| 2019-02-25 | N/A | Authentic Brands Group (ABG) signed a deal with Tilray to capitalize on CBD wellness capabilities. | N/A | View |
| 2018-01-01 | N/A | Tilray entered a partnership with Alef Biotechnology. | Chile | View |
HOUSE_OVERSIGHT_024919.jpg
This document is page 103 of a financial report produced by Cowen on February 25, 2019. It displays 'Rating History' charts for three companies: GW Pharmaceuticals Plc, Tilray, and Turning Point Brands, showing stock prices versus target prices over time (2016-2019). The document is marked with the Bates stamp 'HOUSE_OVERSIGHT_024919' and notes it is intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024917.jpg
This document is an addendum to a Cowen research report dated February 25, 2019, providing mandatory regulatory disclosures and certifications. It lists Canopy Growth, GW Pharmaceuticals, Tilray, and Turning Point Brands as subject companies and details Cowen's investment banking relationships, market making activities, and compensation policies related to these entities. The document also includes a standard disclaimer regarding the informational nature of the report, limitations of liability, and contact information for the compliance department.
HOUSE_OVERSIGHT_024912.jpg
This document is page 96 of a financial research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It contains 'Figure 136 Cannabis Comp Table,' an appendix listing market data and valuations for various cannabis-related companies such as Aphria Inc, Aurora Cannabis Inc, and Level Brands Inc. The document bears a 'HOUSE_OVERSIGHT_024912' stamp, indicating it was part of a document production to the House Oversight Committee, likely obtained from the files of Michael Cella at Cowen.
HOUSE_OVERSIGHT_024900.jpg
This document is page 84 of a Cowen Collaborative Insights market research report dated February 25, 2019. It details the legal and business landscape of the medical cannabis industry in Chile and Colombia, listing various companies involved such as Dayacann, Tilray, and Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as part of a congressional investigation, likely related to financial records or investment bank communications.
HOUSE_OVERSIGHT_024897.jpg
This document is page 81 of a Cowen Collaborative Insights market research report dated February 25, 2019, discussing the regulatory landscape for medical cannabis and CBD in Europe, specifically the UK and Italy. It details the legalization history, licensing requirements involving agencies like the MHRA and FSA, and market activities of companies like GW Pharmaceuticals, Tilray, Bedrocan, Canopy, and Aurora. The document bears a 'HOUSE_OVERSIGHT_024897' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024889.jpg
This document is page 73 of a Cowen financial research report dated February 25, 2019, stamped with a House Oversight Bates number. It details business partnerships in the cannabis/CBD sector, specifically a revenue-sharing agreement between Tilray and Authentic Brands Group (ABG) involving the Nine West brand, and a retail distribution deal between DSW and Green Growth Brands. The document outlines financial terms, including a $100MM-$250MM investment by Tilray, and discusses market expansion opportunities for CBD wellness products.
HOUSE_OVERSIGHT_024888.jpg
This document is page 72 of a Cowen Collaborative Insights report dated February 25, 2019, stamped with a House Oversight Bates number. It details a partnership between Authentic Brands Group (ABG) and Tilray focused on CBD wellness products, mentioning brands like Muhammad Ali and Nine West. It also features a diagram regarding Devan Chemical's CBD-infused textile technology.
HOUSE_OVERSIGHT_024875.jpg
This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024819.jpg
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024813.jpg
This document is a 2018 market landscape infographic titled 'The Green Field 2018' produced by Ackrell Capital. It categorizes dozens of companies within the cannabis industry into sectors including Cultivation, Production Equipment, Testing Services, Dispensaries, E-Commerce, and Distribution Services. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024813', indicating it is part of a document production for the House Oversight Committee, likely related to broader investigations involving financial networks or specific individuals (contextually linked to Epstein investigations via the prompt, though Epstein is not named in this specific image).
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity